【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: mAbs: Overview
• Evolution of mAb therapeutics
• Types of mAbs
• Conjugated cancer therapies using mAbs
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by type of mAbs
• Naked mAbs
• Conjugated mAbs
PART 08: Market segmentation by application
• Global oncology mAbs market
• Global autoimmune and inflammatory mAbs market
• TNF inhibitors
• IL-1 blockers
• PDE4 inhibitors
• Global respiratory mAbs market
• Global ophthalmology mAbs market
PART 09: Geographical segmentation
• Global mAbs market by geographical segmentation 2015-2020
• mAbs market in Americas
• mAbs market in US
• mAbs market in EMEA
• mAbs market in APAC
PART 10: Key leading countries
PART 11: Pipeline portfolio
PART 12: Market drivers
• Reimbursement benefits for mAbs and its biosimilars
• Special regulatory drug designations
• Increase in demand for ADCs
• Increase in industry-academia collaborations
PART 13: Impact of drivers
PART 14: Market challenges0
• Absence of adequate diagnosis and screening procedures
• High manufacturing costs coupled with stringent regulations
• Threat from chemotherapy and off-label drugs
• Difficulties in patient recruitment for conducting clinical trials
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Emergence of biosimilars
• Growing focus of vendors on untapped markets
• Focus on novel mechanisms
• Joint ventures and partnerships for R&D
• Emergence of targeted and combination therapies
PART 17: Vendor landscape
• Competitive scenario
• Key news
• F. Hoffmann-La Roche
• AbbVie
• Johnson & Johnson
• Amgen
• Merck
• BMS
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for mAbs 2015
Exhibit 03: Impact of key customer segments on market 2015
Exhibit 04: Comparison of small molecule and mAbs
Exhibit 05: Preparation of mAbs
Exhibit 06: Types of mAbs
Exhibit 07: Targeted mechanisms of cancer mAbs
Exhibit 08: Patent expiries of top selling mAbs by 2020 in US
Exhibit 09: Patent expiries of top selling mAbs by 2020 in Europe
Exhibit 10: Global mAbs market snapshot: Developed and emerging markets 2015
Exhibit 11: Global mAbs market 2015-2020 ($ billions)
Exhibit 12: Few patient assistance programs offered by various companies
Exhibit 13: Few awareness programs for various cancers, respiratory, and ophthalmology diseases
Exhibit 14: Impact of drivers and challenges on global mAbs market
Exhibit 15: Competitive assessment of marketed and late-stage pipeline molecules
Exhibit 16: Opportunities in mAbs industry today
Exhibit 17: Five forces analysis
Exhibit 18: Approved naked mAbs by US FDA and EU
Exhibit 19: Global mAbs market: Segmentation by application (2015-2020)
Exhibit 20: Global mAbs market: Segmentation by application 2015
Exhibit 21: Global mAbs market segmentation: Growth cycle analysis
Exhibit 22: Annual treatment cost per patient for various oncology drugs 2014
Exhibit 23: Global oncology mAbs market 2015-2020 ($ billions)
Exhibit 24: Opportunity analysis of global oncology mAbs market by type of application
Exhibit 25: Market segmentation by MOA
Exhibit 26: Population aged 60 years and over (millions)
Exhibit 27: Average annual treatment cost of adalimumab, etanercept, and infliximab 2014 ($ millions)
Exhibit 28: Global autoimmune and inflammatory mAbs market 2015-2020 ($ billions)
Exhibit 29: Opportunity analysis of global autoimmune and inflammatory mAbs market by application
Exhibit 30: Global autoimmune and inflammatory mAbs market segmentation by MOA
Exhibit 31: Average percentage of patients receiving TNF inhibitors 2010 and 2015
Exhibit 32: Global autoimmune and inflammatory mAbs market share by MOA 2015
Exhibit 33: Global respiratory mAbs market 2015-2020 ($ billions)
Exhibit 34: Opportunity analysis of global respiratory mAbs market by application
Exhibit 35: Global mAbs market segmentation by application 2015
Exhibit 36: Global ophthalmology mAbs market 2015-2020 ($ billions)
Exhibit 37: Opportunity analysis of global ophthalmology mAbs market by application
Exhibit 38: Global mAbs market: Geography outlook (2015-2020)
Exhibit 39: Global mAbs market: Geography outlook 2015
Exhibit 40: Revenue/growth outlook in different countries/regions 2015
Exhibit 41: mAbs market in Americas 2015-2020 ($ billions)
Exhibit 42: mAbs market in Americas by country 2015
Exhibit 43: mAbs market in US 2015-2020 ($ billions)
Exhibit 44: mAbs market in EMEA 2015-2020 ($ billions)
Exhibit 45: mAbs market in EMEA by country 2015
Exhibit 46: Number of individuals treated with Herceptin through patient assistance programs in China
Exhibit 47: mAbs market in APAC 2015-2020 ($ billions)
Exhibit 48: mAbs market in APAC by country 2015
Exhibit 49: Global mAbs market by geographical segmentation 2015
Exhibit 50: Global mAbs market by geographical segmentation 2020
Exhibit 51: Global mAbs market revenue by geography 2015-2020 ($ billions)
Exhibit 52: Key leading countries
Exhibit 53: Pipeline share of global mAbs market 2015
Exhibit 54: Phase III pipeline molecules for mAbs
Exhibit 55: Phase II pipeline molecules for mAbs
Exhibit 56: Phase I pipeline molecules for mAbs
Exhibit 57: Special regulatory designations approved by US FDA
Exhibit 58: Special regulatory designations approved by EU
Exhibit 59: Impact of drivers
Exhibit 60: Impact of drivers and challenges
Exhibit 61: Expected combination regimen launches in oncology
Exhibit 62: Global mAbs market: Impact assessment of top trends 2015
Exhibit 63: Market presence of vendors in various therapy areas 2015
Exhibit 64: Market share analysis 2015
Exhibit 65: YoY sales comparison of top ten mAbs 2013-2015 ($ billions)
Exhibit 66: Competitive assessment of vendors
Exhibit 67: Key vendors: Geographical presence 2015
Exhibit 68: F. Hoffmann-La Roche: YoY growth and revenue of MabThera/Rituxan 2013-2015 ($ billions)
Exhibit 69: F. Hoffmann-La Roche: Geographic segmentation of MabThera/Rituxan by revenue 2015
Exhibit 70: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 71: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 72: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2013-2015 ($ billions)
Exhibit 73: F. Hoffmann-La Roche: Geographical segmentation of Herceptin 2015
Exhibit 74: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Lucentis 2013-2015 ($ billions)
Exhibit 75: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2013-2015 ($ billions)
Exhibit 76: F. Hoffmann-La Roche: Geographical segmentation of Perjeta 2015
Exhibit 77: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Xolair 2013-2015 ($ billions)
Exhibit 78: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2015 ($ millions)
Exhibit 79: F. Hoffmann-La Roche: Geographical segmentation of Kadcyla 2015
Exhibit 80: Roche: YoY revenue and growth rate of Actemra/RoActemra 2013-2015 ($ billions)
Exhibit 81: Actemra/RoActemra geographic segmentation by revenue 2015
Exhibit 82: F Hoffmann-La Roche: Metrics analysis
Exhibit 83: AbbVie: YoY revenue and growth rate of Humira 2013-2015 ($ billions)
Exhibit 84: AbbVie: YoY revenue and growth rate of Humira (US) 2013-2015 ($ billions)
Exhibit 85: AbbVie: YoY revenue and growth rate of Humira (ROW) 2013-2015 ($ billions)
Exhibit 86: AbbVie: YoY revenue and growth rate of Synagis 2013-2015 ($ millions)
Exhibit 87: AbbVie: Metrics analysis
Exhibit 88: Johnson & Johnson: YoY growth rate and revenue of Remicade 2013-2015 ($ billions)
Exhibit 89: Johnson & Johnson: YoY growth rate and revenue of Remicade (US) 2013-2015 ($ billions)
Exhibit 90: Johnson & Johnson: YoY growth rate and revenue of Remicade (ROW) 2013-2015 ($ billions)
Exhibit 91: Johnson & Johnson: YoY growth rate and revenue of Stelara 2013-2015 ($ billions)
Exhibit 92: Johnson & Johnson: YoY growth rate and revenue of Stelara (US) 2013-2015 ($ millions)
Exhibit 93: Johnson & Johnson: YoY growth rate and revenue of Stelara (ROW) 2013-2015 ($ millions)
Exhibit 94: Johnson & Johnson: YoY growth rate and revenue of Simponi/Simponi Aria 2013-2015 ($ millions)
Exhibit 95: Johnson & Johnson: YoY growth rate and revenue of Simponi/Simponi Aria (US) 2013-2015 ($ millions)
Exhibit 96: Johnson & Johnson: YoY growth rate and revenue of Simponi/Simponi Aria (ROW) 2013-2015 ($ millions)
Exhibit 97: Johnson & Johnson: Metrics analysis
Exhibit 98: Amgen: YoY growth and revenue generated from net product sales of Xgeva 2013-2015 ($ billions)
Exhibit 99: Amgen: Geographic segmentation of Xgeva 2015
Exhibit 100: Amgen: YoY growth and revenue generated from net product sales of Prolia 2013-2015 ($ billions)
Exhibit 101: Amgen: Geographical segmentation of Prolia 2015
Exhibit 102: Amgen: YoY growth and revenue generated from net product sales of Vectibix 2013-2015 ($ millions)
Exhibit 103: Amgen: Geographical segmentation of Vectibix 2015
Exhibit 104: Amgen: Metrics analysis
Exhibit 105: Merck: YoY revenue and growth rate of Remicade (Europe, Russia, and Turkey) 2013-2015 ($ billions)
Exhibit 106: Merck: YoY revenue and growth rate of Simponi (Europe, Russia, and Turkey) 2013-2015 ($ millions)
Exhibit 107: Merck: Metrics analysis
Exhibit 108: BMS: YoY growth and revenue generated from net product sales of Yervoy 2011-2014 ($ billions)
Exhibit 109: BMS: Geographical segmentation of Yervoy 2015
Exhibit 110: BMS: YoY Revenue and growth rate of Erbitux in US and Canada 2013-2015 ($ millions)
Exhibit 111: BMS: Geographical segmentation of Yervoy 2015
Exhibit 112: BMS: Geographical segmentation of Opdivo 2015
Exhibit 113: BMS: Metrics analysis
【レポート販売概要】
■ タイトル：モノクローナル抗体（mAbs）の世界市場2016-2020■ 英文：Global Monoclonal Antibodies Market 2016-2020
■ 発行日：2016年7月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9857
■ 調査対象地域：グローバル
- 建設機械の世界市場予測（～2021）The construction equipment market is projected to grow at a CAGR of 4.11% during the forecast period, to reach a market size of USD 116.20 Billion by 2021, while the mining equipment market is projected to grow at a CAGR of 6.42%, to reach USD 136.03 Billion by 2021. A wide array of upcoming infrastructural projects and the rising demand for commodities has led to an increase in construction and m …
- アジアの睡眠時無呼吸診断装置市場Asia-Pacific Sleep Apnea Diagnostic Systems Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Sleep Apnea Diagnostic Systems Market Outlook to 2021", provides key market data on the Asia-Pacific Sleep Apnea Diagnostic Systems market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments Fixed Polys …
- 大豆誘導体の世界市場：大豆、豆乳、大豆タンパク質濃縮物、大豆油（レシチン）The market for soybean derivatives has made a noteworthy impact on the food & beverage industry and on other industries as well. The soybean crop is processed into soy meal and vegetable oil, and almost all of that meal is used in animal feed. Steady demand for soybean derivatives also confirms sustained need for food-grade soybeans, including specialty varieties, organic, non-GMO, and IP beans. L …
- 世界の自動車ドライバー支援システム市場The global demand for automobiles is increasing at a significant rate since past few years. Due to the global economic downturn, automobile industry witnessed a slight downfall from 2008, where global sales of the vehicles decreased to 68.1 million units from 71.2 million units (2007). The trend continued in 2009, where global vehicle sales further decreased to 65.4 million units. However, the sce …
- 世界の自動車用触媒コンバータ市場2015The Global Automotive Catalytic Converter Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Catalytic Converter industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Catalytic Converter market analysis is provided for the internati …
- 採掘装置レンタルの世界市場：装置タイプ別（露天採掘、地下採掘、粉砕、破砕・スクリーニング装置）、用途別（石炭採掘、金属採掘、鉱物採掘）、地域別予測Global Mining Equipment Rental Market to reach USD xx billion by 2025. Global Mining Equipment Rental Market valued approximately USD xx billion in 2016 is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2017-2025. One of the major drivers for this market is the rental advantages of mining equipment. Companies that function in a specific industry are busine …
- 体外式膜型人工肺（ECMO）機械の世界市場予測（～2021年）The global extracorporeal membrane oxygenation (ECMO) machine market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. The global market is segmented on the basis of modality, application, and region. By modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is accounted for the …
- 2Dパーコードリーダーの世界市場：種類別（携帯型、固定型）、用途別（トラッキング・マーケティング、図書館、駐車場、小売業）、地域別予測Global 2D Barcode Reader Market to reach USD XXX billion by 2025. Global 2D Barcode Reader Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors anticipated augmenting the market are the proficiency of 2D Barcode Reader to adapt an enormous size of information and increased accepta …
- IVF（体外受精）機器の世界市場2017-2021ABSTRACTAbout IVF Devices Infertility is a biological condition which refers to the inability of a person to reproduce. IVF is the most common and effective procedure helpful in assisting pregnancy. IVF is one of the most popular fertility techniques used to treat infertility and related problems in both genders. According to the Centers for Disease Control and Prevention (CDC), about 1.5-2.0 mill …
- 有機基板パッケージング材料の世界市場2015-2019About organic substrate packaging materials Organic substrates are the base layers of individual semiconductor devices and ICs on which other layers are deposited to complete a circuit. As these materials are part of the circuit, it is imperative that they are efficient conductors of electricity, and preferably thinner core materials are used to surround them in demanding system applications. A sm …
- Brominated Vegetable Oilの世界市場Brominated Vegetable Oil (CAS 8016-94-2) Market Research Report 2014 presents comprehensive data on brominated vegetable oil markets globally and regionally (Europe, Asia, North America etc.) The report includes brominated vegetable oil description, covers its application areas and related patterns. It overviews brominated vegetable oil market, names brominated vegetable oil producers and indicate …
- クラウドコラボレーションソリューションの世界市場予測（～2021）MarketsandMarkets forecasts the cloud collaboration market size to grow from USD 23.39 Billion in 2016 to USD 42.57 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 12.7% from 2016 to 2021. The emerging trend of mobility & BYOD and the need for secure & efficient solutions which can enhance the employee’s productivity are the key driving factors of market. With the rising adoption of cl …
- 世界の自動車用エアフィルター市場動向（2014-2018）About Automotive Air Filters Automotive air filters are used in vehicles to filter air and stop dirt particles entering the air inlet of internal combustion engines. Air filters are extremely beneficial as they ensure a sufficient amount of air for improved ignition. Dirt particles can cause damage to an engine and have a negative impact on engine performance. Growing concerns about emissions and …
- 紙コップ・紙容器の世界市場2017-2021ABSTRACTAbout Paper Cups and Containers Paper cups are usually coated with PE, which provides stability and heat resistance. However, these PE-coated paper cups are hard to recycle and do not decompose easily, which results in large amounts of paper cups piling up in landfills. Disposable containers are primarily made of paperboard, which is a little thicker than paper. These containers are usuall …
- 血管肉腫(Angiosarcoma)：世界の治験レビュー（2015年上半期版）Angiosarcoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2015" provides data on the Angiosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angiosarcoma. It includes an overview of the trial numbers and their recruitment status as per the sit …
